Chromatin regulators and their impact on DNA repair and G2 checkpoint recovery

References

• Aguilera A, Gomez-Gonzalez B. Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet. 2008 Mar;9(3):204–217.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000 Jan 7;100(1):57–70.
   PubMed Web of Science ®Google Scholar
• McKinnon PJ, Caldecott KW. DNA strand break repair and human genetic disease. Annu Rev Genomics Hum Genet. 2007;8:37–55.
   PubMed Web of Science ®Google Scholar
• Rass U, Ahel I, West SC. Defective DNA repair and neurodegenerative disease. Cell. 2007 Sept 21;130(6):991–1004.
   PubMed Web of Science ®Google Scholar
• Hasty P, Campisi J, Hoeijmakers J, et al. Aging and genome maintenance: lessons from the mouse? Science. 2003 Feb 28;299(5611):1355–1359.
   PubMed Web of Science ®Google Scholar
• Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009 Oct 22;461(7267):1071–1078.
   PubMed Web of Science ®Google Scholar
• Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 2001 Sept 1;15(17):2177–2196.
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Ballif BA, Smogorzewska A, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007 May 25;316(5828):1160–1166.
   PubMed Web of Science ®Google Scholar
• van Vugt MA, Bras A, Medema RH. Restarting the cell cycle when the checkpoint comes to a halt. Cancer Res. 2005 Aug 15;65(16):7037–7040.
   PubMed Web of Science ®Google Scholar
• Macurek L, Lindqvist A, Lim D, et al. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature. 2008 Sept 4;455(7209):119–123.
   PubMed Web of Science ®Google Scholar
• van Vugt M, Medema RH. Checkpoint adaptation and recovery: back with Polo after the break. Cell Cycle. 2004 Nov;3(11):1383–1386.
   PubMed Web of Science ®Google Scholar
• Mamely I, Vugt M, Smits VA, et al. Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery. Curr Biol. 2006 Oct 10;16(19):1950–1955.
   PubMed Web of Science ®Google Scholar
• Mailand N, Bekker-Jensen S, Bartek J, et al. Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Mol Cell. 2006 Aug 4;23(3):307–318.
   PubMed Web of Science ®Google Scholar
• Peschiaroli A, Dorrello NV, Guardavaccaro D, et al. SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol Cell. 2006 Aug 4;23(3):319–329.
   PubMed Web of Science ®Google Scholar
• Freire R, Vugt M, Mamely I, et al. Claspin: timing the cell cycle arrest when the genome is damaged. Cell Cycle. 2006 Dec;5(24):2831–2834.
   PubMed Web of Science ®Google Scholar
• Macurek L, Lindqvist A, Voets O, et al. Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition. Oncogene. 2010 Apr 15;29(15):2281–2291.
   PubMed Web of Science ®Google Scholar
• Lu X, Nannenga B, Donehower LA. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev. 2005 May 15;19(10):1162–1174.
   PubMed Web of Science ®Google Scholar
• Lindqvist A, de Bruijn M, Macurek L, et al. Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression. Embo J. 2009 Oct 21;28(20):3196–3206.
   PubMed Web of Science ®Google Scholar
• Papamichos-Chronakis M, Peterson CL. Chromatin and the genome integrity network. Nat Rev Genet. 2013 Jan;14(1):62–75.
   PubMed Web of Science ®Google Scholar
• Koundrioukoff S, Polo S, Almouzni G. Interplay between chromatin and cell cycle checkpoints in the context of ATR/ATM-dependent checkpoints. DNA Repair (Amst). 2004 Aug-Sept;3(8–9):969–978.
   PubMed Web of Science ®Google Scholar
• Warmerdam DO, Kanaar R. Dealing with DNA damage: relationships between checkpoint and repair pathways. Mutat Res. 2010 Apr-June;704(1–3):2–11.
   PubMed Web of Science ®Google Scholar
• Deem AK, Li X, Tyler JK. Epigenetic regulation of genomic integrity. Chromosoma. 2012 Apr;121(2):131–151.
   PubMed Web of Science ®Google Scholar
• Burma S, Chen BP, Murphy M, et al. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem. 2001 Nov 9;276(45):42462–42467.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Brickner JR, Majid MC, et al. Crosstalk between ubiquitin and other post-translational modifications on chromatin during double-strand break repair. Trends Cell Biol. 2014 July;24(7):426–434.
   PubMed Web of Science ®Google Scholar
• Taverna SD, Li H, Ruthenburg AJ, et al. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol. 2007 Nov;14(11):1025–1040.
   PubMed Web of Science ®Google Scholar
• van Attikum H, Gasser SM. Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol. 2009 May;19(5):207–217.
   PubMed Web of Science ®Google Scholar
• Soria G, Polo SE, Almouzni G. Prime, repair, restore: the active role of chromatin in the DNA damage response. Mol Cell. 2012 June 29;46(6):722–734.
   PubMed Web of Science ®Google Scholar
• Smeenk G, van Attikum H. The chromatin response to DNA breaks: leaving a mark on genome integrity. Annu Rev Biochem. 2013;82:55–80.
   PubMed Web of Science ®Google Scholar
• Linger JG, Tyler JK. Chromatin disassembly and reassembly during DNA repair. Mutat Res. 2007 May 1;618(1–2):52–64.
   PubMed Web of Science ®Google Scholar
• Kruhlak MJ, Celeste A, Dellaire G, et al. Changes in chromatin structure and mobility in living cells at sites of DNA double-strand breaks. J Cell Biol. 2006 Mar 13;172(6):823–834.
   PubMed Web of Science ®Google Scholar
• Tsukuda T, Fleming AB, Nickoloff JA, et al. Chromatin remodelling at a DNA double-strand break site in Saccharomyces cerevisiae. Nature. 2005 Nov 17;438(7066):379–383.
   PubMed Web of Science ®Google Scholar
• Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem. 2009;78:273–304.
   PubMed Web of Science ®Google Scholar
• Luijsterburg MS, van Attikum H. Chromatin and the DNA damage response: the cancer connection. Mol Oncol. 2011 Aug;5(4):349–367.
   PubMed Web of Science ®Google Scholar
• Warmerdam DO, Alonso-de Vega I, Wiegant WW, et al. PHF6 promotes non-homologous end joining and G2 checkpoint recovery. EMBO Rep. 2020 Jan 7;21(1):e48460.
   PubMed Web of Science ®Google Scholar
• Cai Y, Jin J, Tomomori-Sato C, et al. Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex. J Biol Chem. 2003 Oct 31;278(44):42733–42736.
   PubMed Web of Science ®Google Scholar
• Doyon Y, Cote J. The highly conserved and multifunctional NuA4 HAT complex. Curr Opin Genet Dev. 2004 Apr;14(2):147–154.
   PubMed Web of Science ®Google Scholar
• Lee KK, Workman JL. Histone acetyltransferase complexes: one size doesn’t fit all. Nat Rev Mol Cell Biol. 2007 Apr;8(4):284–295.
   PubMed Web of Science ®Google Scholar
• Price BD, D’Andrea AD. Chromatin remodeling at DNA double-strand breaks. Cell. 2013 Mar 14;152(6):1344–1354.
   PubMed Web of Science ®Google Scholar
• Sun Y, Jiang X, Chen S, et al. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc Natl Acad Sci U S A. 2005 Sept 13;102(37):13182–13187.
   PubMed Web of Science ®Google Scholar
• Squatrito M, Gorrini C, Amati B. Tip60 in DNA damage response and growth control: many tricks in one HAT. Trends Cell Biol. 2006 Sept;16(9):433–442.
   PubMed Web of Science ®Google Scholar
• Kaidi A, Jackson SP. KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling. Nature. 2013 June 6;498(7452):70–74.
   PubMed Web of Science ®Google Scholar
• Ikura T, Tashiro S, Kakino A, et al. DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics. Mol Cell Biol. 2007 Oct;27(20):7028–7040.
   PubMed Web of Science ®Google Scholar
• Tang Y, Luo J, Zhang W, et al. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell. 2006 Dec 28;24(6):827–839.
   PubMed Web of Science ®Google Scholar
• Barlev NA, Liu L, Chehab NH, et al. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell. 2001 Dec;8(6):1243–1254.
   PubMed Web of Science ®Google Scholar
• Tang J, Cho NW, Cui G, et al. Acetylation limits 53BP1 association with damaged chromatin to promote homologous recombination. Nat Struct Mol Biol. 2013 Mar;20(3):317–325.
   PubMed Web of Science ®Google Scholar
• Kusch T, Florens L, Macdonald WH, et al. Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science. 2004 Dec 17;306(5704):2084–2087.
   PubMed Web of Science ®Google Scholar
• Jha S, Shibata E, Dutta A. Human Rvb1/Tip49 is required for the histone acetyltransferase activity of Tip60/NuA4 and for the downregulation of phosphorylation on H2AX after DNA damage. Mol Cell Biol. 2008 Apr;28(8):2690–2700.
   PubMed Web of Science ®Google Scholar
• Shaltiel IA, Krenning L, Bruinsma W, et al. The same, only different - DNA damage checkpoints and their reversal throughout the cell cycle. J Cell Sci. 2015 Feb 15;128(4):607–620.
   PubMed Web of Science ®Google Scholar
• Xu Y, Sun Y, Jiang X, et al. The p400 ATPase regulates nucleosome stability and chromatin ubiquitination during DNA repair. J Cell Biol. 2010 Oct 4;191(1):31–43.
   PubMed Web of Science ®Google Scholar
• Judes G, Rifai K, Ngollo M, et al. A bivalent role of TIP60 histone acetyl transferase in human cancer. Epigenomics. 2015;7(8):1351–1363.
   PubMed Web of Science ®Google Scholar
• Coffey K, Blackburn TJ, Cook S, et al. Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer. PLoS One. 2012;7(10):e45539.
   PubMed Web of Science ®Google Scholar
• Watrin E, Peters JM. The cohesin complex is required for the DNA damage-induced G2/M checkpoint in mammalian cells. Embo J. 2009 Sept 2;28(17):2625–2635.
   PubMed Web of Science ®Google Scholar
• Watrin E, Peters JM. Cohesin and DNA damage repair. Exp Cell Res. 2006 Aug 15;312(14):2687–2693.
   PubMed Web of Science ®Google Scholar
• Tan TL, Kanaar R, Wyman C. Rad54, a Jack of all trades in homologous recombination. DNA Repair (Amst). 2003 July 16;2(7):787–794.
   PubMed Web of Science ®Google Scholar
• Yazdi PT, Wang Y, Zhao S, et al. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev. 2002 Mar 1;16(5):571–582.
   PubMed Web of Science ®Google Scholar
• Bot C, Pfeiffer A, Giordano F, et al. Independent mechanisms recruit the cohesin loader protein NIPBL to sites of DNA damage. J Cell Sci. 2017 Mar 15;130(6):1134–1146.
   PubMed Web of Science ®Google Scholar
• Todd MA, Ivanochko D, Picketts DJ. PHF6 degrees of separation: the multifaceted roles of a chromatin adaptor protein. Genes (Basel). 2015 June 19;6(2):325–352.
   PubMed Web of Science ®Google Scholar
• Sanchez R, Zhou MM. The PHD finger: a versatile epigenome reader. Trends Biochem Sci. 2011 July;36(7):364–372.
   PubMed Web of Science ®Google Scholar
• Todd MA, Picketts DJ. PHF6 interacts with the nucleosome remodeling and deacetylation (NuRD) complex. J Proteome Res. 2012 Aug 3;11(8):4326–4337.
   PubMed Web of Science ®Google Scholar
• Soto-Feliciano YM, Bartlebaugh JME, Liu Y, et al. PHF6 regulates phenotypic plasticity through chromatin organization within lineage-specific genes. Genes Dev. 2017 May 15;31(10):973–989.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li F, Ruan K, et al. Structural and functional insights into the human Borjeson-Forssman-Lehmann syndrome-associated protein PHF6. J Biol Chem. 2014 Apr 4;289(14):10069–10083.
   PubMed Web of Science ®Google Scholar
• Wang J, Leung JW, Gong Z, et al. PHF6 regulates cell cycle progression by suppressing ribosomal RNA synthesis. J Biol Chem. 2013 Feb 1;288(5):3174–3183.
   PubMed Web of Science ®Google Scholar
• Todd MA, Huh MS, Picketts DJ. The sub-nucleolar localization of PHF6 defines its role in rDNA transcription and early processing events. Eur J Hum Genet. 2016 Oct;24(10):1453–1459.
   PubMed Web of Science ®Google Scholar
• Xiang J, Wang G, Xia T, et al. The depletion of PHF6 decreases the drug sensitivity of T-cell acute lymphoblastic leukemia to prednisolone. Biomed Pharmacother. 2019 Jan;109:2210–2217.
   PubMed Web of Science ®Google Scholar
• Zhang C, Mejia LA, Huang J, et al. The X-linked intellectual disability protein PHF6 associates with the PAF1 complex and regulates neuronal migration in the mammalian brain. Neuron. 2013 June 19;78(6):986–993.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li F, Zhang B, et al. Structural basis of plant homeodomain finger 6 (PHF6) recognition by the retinoblastoma binding protein 4 (RBBP4) component of the nucleosome remodeling and deacetylase (NuRD) complex. J Biol Chem. 2015 Mar 6;290(10):6630–6638.
   PubMed Web of Science ®Google Scholar
• Luijsterburg MS, de Krijger I, Wiegant WW, et al. PARP1 links CHD2-mediated chromatin expansion and H3.3 deposition to DNA repair by non-homologous end-joining. Mol Cell. 2016 Feb 18;61(4):547–562.
   PubMed Web of Science ®Google Scholar
• Smeenk G, Wiegant WW, Vrolijk H, et al. The NuRD chromatin-remodeling complex regulates signaling and repair of DNA damage. J Cell Biol. 2010 Sept 6;190(5):741–749.
   PubMed Web of Science ®Google Scholar
• Pan MR, Hsieh HJ, Dai H, et al. Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment. J Biol Chem. 2012 Feb 24;287(9):6764–6772.
   PubMed Web of Science ®Google Scholar
• Gong F, Chiu LY, Cox B, et al. Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination. Genes Dev. 2015 Jan 15;29(2):197–211.
   PubMed Web of Science ®Google Scholar
• Spruijt CG, Luijsterburg MS, Menafra R, et al. ZMYND8 co-localizes with NuRD on target genes and regulates poly(ADP-Ribose)-dependent recruitment of GATAD2A/NuRD to sites of DNA damage. Cell Rep. 2016 Oct 11;17(3):783–798.
   PubMed Web of Science ®Google Scholar
• Savitsky P, Krojer T, Fujisawa T, et al. Multivalent histone and DNA engagement by a PHD/BRD/PWWP triple reader cassette recruits ZMYND8 to K14ac-rich chromatin. Cell Rep. 2016 Dec 6;17(10):2724–2737.
   PubMed Web of Science ®Google Scholar
• Miller KM, Tjeertes JV, Coates J, et al. Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat Struct Mol Biol. 2010 Sept;17(9):1144–1151.
   PubMed Web of Science ®Google Scholar
• Marnef A, Legube G. Organizing DNA repair in the nucleus: DSBs hit the road. Curr Opin Cell Biol. 2017 June;46:1–8.
   PubMed Web of Science ®Google Scholar
• Ray Chaudhuri A, Nussenzweig A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat Rev Mol Cell Biol. 2017 Oct;18(10):610–621.
   PubMed Web of Science ®Google Scholar
• Miyagi S, Sroczynska P, Kato Y, et al. The chromatin-binding protein Phf6 restricts the self-renewal of hematopoietic stem cells. Blood. 2019 June 6;133(23):2495–2506.
   PubMed Web of Science ®Google Scholar
• Awwad SW, Abu-Zhayia ER, Guttmann-Raviv N, et al. NELF-E is recruited to DNA double-strand break sites to promote transcriptional repression and repair. EMBO Rep. 2017 May;18(5):745–764.
   PubMed Web of Science ®Google Scholar
• Abu-Zhayia ER, Awwad SW, Ben-Oz BM, et al. CDYL1 fosters double-strand break-induced transcription silencing and promotes homology-directed repair. J Mol Cell Biol. 2018 Aug 1;10(4):341–357.
   PubMed Web of Science ®Google Scholar
• Voss AK, Gamble R, Collin C, et al. Protein and gene expression analysis of Phf6, the gene mutated in the Borjeson-Forssman-Lehmann Syndrome of intellectual disability and obesity. Gene Expr Patterns. 2007 Oct;7(8):858–871.
   PubMed Web of Science ®Google Scholar
• Crawford J, Lower KM, Hennekam RC, et al. Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient. J Med Genet. 2006 Mar;43(3):238–243.
   PubMed Web of Science ®Google Scholar
• Visootsak J, Rosner B, Dykens E, et al. Clinical and behavioral features of patients with Borjeson-Forssman-Lehmann syndrome with mutations in PHF6. J Pediatr. 2004 Dec;145(6):819–825.
   PubMed Web of Science ®Google Scholar
• Turner G, Lower KM, White SM, et al. The clinical picture of the Borjeson-Forssman-Lehmann syndrome in males and heterozygous females with PHF6 mutations. Clin Genet. 2004 Mar;65(3):226–232.
   PubMed Web of Science ®Google Scholar
• McRae HM, Garnham AL, Hu Y, et al. PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia. Blood. 2019 Apr 18;133(16):1729–1741.
   PubMed Web of Science ®Google Scholar
• Miyagi S, Iwama A. Plant homeodomain finger protein 6 in the regulation of normal and malignant hematopoiesis. Curr Opin Hematol. 2020 July;27(4):248–253.
   PubMed Web of Science ®Google Scholar
• Hsu YC, Chen TC, Lin CC, et al. Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials. Blood Adv. 2019 Aug 13;3(15):2355–2367.
   PubMed Web of Science ®Google Scholar
• Hiddingh L, Raktoe RS, Jeuken J, et al. Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis. Sci Rep. 2014 June;11(4):5260.
   Google Scholar
• Van Vlierberghe P, Patel J, Abdel-Wahab O, et al. PHF6 mutations in adult acute myeloid leukemia. Leukemia. 2011 Jan;25(1):130–134.
   PubMed Web of Science ®Google Scholar
• Van Vlierberghe P, Palomero T, Khiabanian H, et al. PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet. 2010 Apr;42(4):338–342.
   PubMed Web of Science ®Google Scholar
• Hajjari M, Salavaty A, Crea F, et al. The potential role of PHF6 as an oncogene: a genotranscriptomic/proteomic meta-analysis. Tumour Biol. 2016 Apr;37(4):5317–5325.
   PubMedGoogle Scholar
• Marks DI, Rowntree C. Management of adults with T-cell lymphoblastic leukemia. Blood. 2017 Mar 2;129(9):1134–1142.
   PubMed Web of Science ®Google Scholar
• Hodby KA, Marks DI. Recent advances in the management of acute lymphoblastic leukaemia. Curr Treat Options Oncol. 2020 Feb 20;21(3):23,020–0712-8.
   PubMed Web of Science ®Google Scholar